PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation

Journal of Cell Science

Volumn 125, Issue 9, 2012, Pages 2276-2287

  Hewitt, Kyle J ^a   Shamis, Yulia ^a   Knight, Elana ^c   Smith, Avi ^c   Maione, Anna ^a   Alt Holland, Addy ^d   Sheridan, Steven D ^b   Haggarty, Stephen J ^b   Garlick, Jonathan A ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TUFTS UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

3D tissues; DNA methylation; Fibroblasts; Human embryonic stem cells; Induced pluripotent stem cells; PDGFR

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CPG ISLAND; DNA DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

CELL DIFFERENTIATION; CELL MOVEMENT; CPG ISLANDS; DNA; DNA METHYLATION; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PROMOTER REGIONS, GENETIC; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;

EID: 84862903434     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.099192     Document Type: Article

References (48)

1. Abramsson, A., Lindblom, P. and Betsholtz, C. (2003). Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112, 1142-1151.
2. Andrae, J., Gallini, R. and Betsholtz, C. (2008). Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22, 1276-1312.
3. Aranda, P., Agirre, X., Ballestar, E., Andreu, E. J., Román-Gómez, J., Prieto, I., Martín-Subero, J. I., Cigudosa, J. C., Siebert, R., Esteller, M. et al. (2009). Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS ONE 4, e7809.
4. Bajada, S., Mazakova, I., Richardson, J. B. and Ashammakhi, N. (2008). Updates on stem cells and their applications in regenerative medicine. J. Tissue Eng. Regen. Med. 2, 169-183.
5. Ball, S. G., Shuttleworth, C. A. and Kielty, C. M. (2007). Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J. Cell. Mol. Med. 11, 1012-1030.
6. Barberi, T., Willis, L. M., Socci, N. D. and Studer, L. (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2, e161.
7. Bernardo, M. E., Locatelli, F. and Fibbe, W. E. (2009). Mesenchymal stromal cells. Ann. N. Y. Acad. Sci. 1176, 101-117.
8. Betsholtz, C. (2004). Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev. 15, 215-228.
9. Bock, C., Reither, S., Mikeska, T., Paulsen, M., Walter, J. and Lengauer, T. (2005). BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21, 4067-4068.
10. Bonner, J. C. (2004). Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 15, 255-273.
11. Chen, T., Ueda, Y., Dodge, J. E., Wang, Z. and Li, E. (2003). Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23, 5594-5605.
12. da Silva Meirelles, L., Caplan, A. I. and Nardi, N. B. (2008). In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26, 2287-2299.
13. Egging, D. F., van Vlijmen, I., Starcher, B., Gijsen, Y., Zweers, M. C., Blankevoort, L., Bristow, J. and Schalkwijk, J. (2006). Dermal connective tissue development in mice: an essential role for tenascin-X. Cell Tissue Res. 323, 465-474.
14. English, K., French, A. and Wood, K. J. (2010). Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7, 431-442.
15. Fernandez, A. F., Assenov, Y., Martin-Subero, J. I., Balint, B., Siebert, R., Taniguchi, H., Yamamoto, H., Hidalgo, M., Tan, A. C., Galm, O. et al. (2012). A DNA methylation fingerprint of 1,628 human samples. Genome Res. 22, 407-419.
16. Friedl, P. and Bröcker, E.-B. (2000). The biology of cell locomotion within threedimensional extracellular matrix. Cell. Mol. Life Sci. 57, 41-64.
17. Gan, Q., Yoshida, T., McDonald, O. G. and Owens, G. K. (2007). Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 25, 2-9.
18. Gao, Z., Sasaoka, T., Fujimori, T., Oya, T., Ishii, Y., Sabit, H., Kawaguchi, M., Kurotaki, Y., Naito, M., Wada, T. et al. (2005). Deletion of the PDGFR-beta gene affects key fibroblast functions important for wound healing. J. Biol. Chem. 280, 9375-9389.
19. Heldin, C. H. and Westermark, B. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316.
20. Hewitt, K. J., Shamis, Y., Carlson, M. W., Aberdam, E., Aberdam, D. and Garlick, J. A. (2009). Three-dimensional epithelial tissues generated from human embryonic stem cells. Tissue Eng. Part A 15, 3417-3426.
21. Hewitt, K. J., Shamis, Y., Hayman, R. B., Margvelashvili, M., Dong, S., Carlson, M. W. and Garlick, J. A. (2011). Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. PLoS ONE 6, e17128.
22. Hupkes, M., van Someren, E. P., Middelkamp, S. H., Piek, E., van Zoelen, E. J. and Dechering, K. J. (2011). DNA methylation restricts spontaneous multi-lineage differentiation of mesenchymal progenitor cells, but is stable during growth factorinduced terminal differentiation. Biochim. Biophys. Acta 1813, 839-849.
23. Khavari, D. A., Sen, G. L. and Rinn, J. L. (2010). DNA methylation and epigenetic control of cellular differentiation. Cell Cycle 9, 3880-3883.
24. Laurent, L., Wong, E., Li, G., Huynh, T., Tsirigos, A., Ong, C. T., Low, H. M., Kin Sung, K. W., Rigoutsos, I., Loring, J. et al. (2010). Dynamic changes in the human methylome during differentiation. Genome Res. 20, 320-331.
25. Lian, Q., Zhang, Y., Zhang, J., Zhang, H. K., Wu, X., Zhang, Y., Lam, F. F., Kang, S., Xia, J. C., Lai, W. H. et al. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121, 1113-1123.
26. Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G., Antosiewicz-Bourget, J., O'Malley, R., Castanon, R., Klugman, S. et al. (2011). Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73.
27. Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R. et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70.
28. Majore, I., Moretti, P., Stahl, F., Hass, R. and Kasper, C. (2011). Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev. 7, 17-31.
29. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S. and Meissner, A. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55.
30. Noer, A., Sørensen, A. L., Boquest, A. C. and Collas, P. (2006). Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue. Mol. Biol. Cell 17, 3543-3556.
31. Ohi, Y., Qin, H., Hong, C., Blouin, L., Polo, J. M., Guo, T., Qi, Z., Downey, S. L., Manos, P. D., Rossi, D. J. et al. (2011). Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 13, 541-549.
32. Pawlak, M. and Jaenisch, R. (2011). De novo DNA methylation by Dnmt3a and Dnmt3b is dispensable for nuclear reprogramming of somatic cells to a pluripotent state. Genes Dev. 25, 1035-1040.
33. Pierce, G. F., Tarpley, J. E., Yanagihara, D., Mustoe, T. A., Fox, G. M. and Thomason, A. (1992). Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am. J. Pathol. 140, 1375-1388.
34. Polo, J.M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T. et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28, 848-855.
35. Pouyani, T., Ronfard, V., Scott, P. G., Dodd, C. M., Ahmed, A., Gallo, R. L. and Parenteau, N. L. (2009). De novo synthesis of human dermis in vitro in the absence of a three-dimensional scaffold. In Vitro Cell. Dev. Biol. Anim. 45, 430-441.
36. Riazi, A. M., Kwon, S. Y. and Stanford, W. L. (2009). Stem cell sources for regenerative medicine. Methods Mol. Biol. 482, 55-90.
37. Shamis, Y., Hewitt, K. J., Carlson, M. W., Margvelashvilli, M., Dong, S., Kuo, C. K., Daheron, L., Egles, C. and Garlick, J. A. (2011). Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents. Stem Cell Res. Ther. 2, 10.
38. Sheridan, S. D., Theriault, K. M., Reis, S. A., Zhou, F., Madison, J. M., Daheron, L., Loring, J. F. and Haggarty, S. J. (2011). Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE 6, e26203.
39. Sørensen, A. L., Timoskainen, S., West, F. D., Vekterud, K., Boquest, A. C., Ahrlund-Richter, L., Stice, S. L. and Collas, P. (2010). Lineage-specific promoter DNA methylation patterns segregate adult progenitor cell types. Stem Cells Dev. 19, 1257-1266.
40. Sottile, J., Shi, F., Rublyevska, I., Chiang, H. Y., Lust, J. and Chandler, J. (2007). Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin. Am. J. Physiol. Cell Physiol. 293, C1934-C1946.
41. Steed, D. L. (1995). Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J. Vasc. Surg. 21, 71-78; discussion 79-81.
42. Suhr, S. T., Chang, E. A., Rodriguez, R. M., Wang, K., Ross, P. J., Beyhan, Z., Murthy, S. and Cibelli, J. B. (2009). Telomere dynamics in human cells reprogrammed to pluripotency. PLoS ONE 4, e8124.
43. Suhr, S. T., Chang, E. A., Tjong, J., Alcasid, N., Perkins, G. A., Goissis, M. D., Ellisman, M. H., Perez, G. I. and Cibelli, J. B. (2010). Mitochondrial rejuvenation after induced pluripotency. PLoS ONE 5, e14095.
44. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S. and Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
45. Trojanowska, M. (2008). Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology (Oxford) 47 Suppl 5, v2-v4.
46. Veevers-Lowe, J., Ball, S. G., Shuttleworth, A. and Kielty, C. M. (2011). Mesenchymal stem cell migration is regulated by fibronectin through a5b1-integrin-mediated activation of PDGFR-b and potentiation of growth factor signals. J. Cell Sci. 124, 1288-1300.
47. Wiench, M., John, S., Baek, S., Johnson, T. A., Sung, M. H., Escobar, T., Simmons, C. A., Pearce, K. H., Biddie, S. C., Sabo, P. J. et al. (2011). DNA methylation status predicts cell type-specific enhancer activity. EMBO J. 30, 3028-3039.
48. Yi, E. S., Lee, H., Yin, S., Piguet, P., Sarosi, I., Kaufmann, S., Tarpley, J., Wang, N. S. and Ulich, T. R. (1996). Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. Am. J. Pathol. 149, 539-548.